Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LungenClinic Grosshansdorf is a German specialty hospital focused on diseases of the lungs and respiratory tract, with core clinical departments in pneumology, oncology, thoracic surgery, and anesthesiology. It operates as a certified lung center and provides inpatient and outpatient diagnosis, treatment, rehabilitation-related respiratory care, and thoracic surgical services. The organization is research-active, participates in pulmonary studies, and collaborates with major academic and translational respiratory research networks in northern Germany. Although the requested name includes "Asklepios," the entity that exactly matches the clinic website and legal imprint is LungenClinic Grosshansdorf GmbH rather than an Asklepios-branded operating company. This is a healthcare delivery organization, not a drug-development biotech company, and it does not appear to have a proprietary therapeutic pipeline in the biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asklepios Lung Clinic.